Andrew Michael

Andrew Michael, MD, is an accomplished clinical development specialist with extensive experience in clinical research and oversight. Currently serving at Pacific Clinical Research, LLC since December 2016, Andrew is responsible for developing and amending interventional drug study protocols while providing leadership for collaborative efforts across global and regional teams. As the founder of MyTrial Inc. since July 2019, Andrew has also demonstrated entrepreneurial skills in the clinical trial sector. Previously, Andrew held the position of Senior Clinical Research Associate at OncoC4, Inc. and Covance, overseeing comprehensive site monitoring, adherence to study protocols, and management of study feasibility. Earlier roles include serving as a clinical research physician at Veterans Health Administration/UCSD, where Andrew contributed to government research projects, and experience as a Clinical Research Assistant at KV Pharmaceuticals. Andrew's academic credentials include an MD from Ross University School of Medicine and ongoing business education at Stanford University Graduate School of Business.